TC BioPharm (Holdings) plc Quarterly Operating Lease, Right-of-Use Asset in GBP from Q4 2022 to Q1 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TC BioPharm (Holdings) plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q1 2024.
  • TC BioPharm (Holdings) plc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was £1.29M.
Operating Lease, Right-of-Use Asset, Quarterly (GBP)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.29M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.34M -190K -12.4% Dec 31, 2023 10-Q 2024-05-15
Q4 2022 1.53M Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.